International Premium Cannabis Cultivator

Akanda is an international medical cannabis and wellness platform company seeking to help people lead better lives through improved access to high-quality and affordable products.

MEDICAL CANNABIS

Akanda has multiple gateways to international markets for medical cannabis

Akanda’s portfolio includes Holigen, a Portugal-based cultivator, manufacturer, and distributor with a prized EU GMP-certified premium indoor grow facility; and CanMart, a UK-based fully licensed pharmaceutical importer and distributor which supplies pharmacies and clinics within the UK.

Premium Cannabis Cultivator

We expect to expand our subsidiaries’ local operations and develop sales channels of our medicinal-grade cannabis products and cannabis based medical and wellness products

Medical Cannabis

Manufacturing and supplying high quality and efficacious medical cannabis and wellness products to improve quality of life for consumers in legal markets

Pharma Quality

Akanda’s purpose-built indoor grow facility is the only one of its kind that can produce medical cannabis equivalent to the recreational grades available in North America.

Patient Access

Providing cannabis-based medicine to international patients through leading prescribing doctors, digital pain clinics and distribution partners

Our Leadership team.

Katie Field

Ms. Field is currently the Interim CEO and Director. (NEO: HALO) (OTCQX: HCANF) (“HALO”), a position she has held since February 2022. From April 2019 through February 2020, Ms. Field served as Chief Strategy Officer at HALO. Ms. Field’s resume includes senior positions at The Brookings Institution and Bain & Company. In 2014 she entered the cannabis industry and led the procurement, build out, and sale of one of five original vertically integrated companies with state licenses in Florida. Subsequently, Ms. Field operated a strategy consulting practice focused on cannabis and also worked at MariMed in 2018 as Executive Vice President of Corporate Development. She completed an internship in the public liaison’s office of The White House during the George W. Bush administration. Ms. Field holds an MBA from Columbia Business School and a BA with honors from Stanford University.

Board of Directors

Jatinder Dhaliwal

Mr. Jatinder Dhaliwal is a registered pharmacist, and has significant capital markets experience. He has served as CEO and director of multiple publicly traded cannabis companies. He has served as a director of a licensed producer and extractor. He has extensive knowledge in agricultural, medical and pharmaceutical operations. Mr. Dhaliwal is well-versed in the cannabis market from seed to sale, including cultivation, extraction, manufacturing, distribution and quality control of cannabis flower, oils, and concentrates. Mr. Dhaliwal is a certified medical cannabis practitioner. He has overseen operations of numerous retail and commercial operations and implemented various health protocols and technology advances into health and wellness chains. Mr. Dhaliwal holds a Bachelor of Pharmacy from the University of British Columbia and a Bachelor of Science in Biology from the University of Victoria.

David Jenkins

David Jenkins has served as one of our directors and as a member of our Audit Committee and our Compensation Committee since February 2023. Mr. Jenkins is currently a director at Binovi Technologies Corp., a position that he has held since December 2021; a director at Kiaro Holdings Corp. (TSXV: KO), a position that he has held since August 2022; a director at Levitee Labs., a position that he has held since January 2022; a director at Pontus Protein Ltd. (TSXV: HULK), a position that he has held since March 2022; a director at Boundary Gold & Copper Mining Ltd., a position that he has held since July 2020; a director at Montego Resources Inc., a position that he has held since January 2020; and a director at Quantum Battery Metals Corp., a position that he has held since January 2020.